Pfizer Receives FDA Approval for RSV Vaccine – The Wall Street Journal

Pfizer Receives FDA Approval for RSV Vaccine  The Wall Street JournalWith expanded FDA nod for RSV shot Abrysvo, Pfizer gains edge on GSK’s Arexvy. But will it amount to much?  FiercePharmaHealthCentral: Which RSV Vaccine Is Right for You?  Cedars-SinaiStudy finds RSV vaccine highly effective in protecting older adults against severe disease, hospitalization and death  Medical XpressPfizer’s RSVpreF Vaccine Shows Efficacy in High-Risk Adults Aged 18-59  Contagionlive.com